Adverse Event Clinical Research
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

: medication-request-example-tucatinib - XML Representation

Page standards status: Informative

Raw xml | Download



<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="medication-request-example-tucatinib"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="medication-request-example-tucatinib"> </a><a name="hcmedication-request-example-tucatinib"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest &quot;medication-request-example-tucatinib&quot; </p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><h3>Medications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>tucatinib 150 MG Oral Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#2361290)</span></td></tr></table><p><b>subject</b>: <a href="Patient-patient-example-kaitlyn-b.html">Patient/patient-example-kaitlyn-b</a> &quot; BOUNCE&quot;</p><p><b>authoredOn</b>: 2020-03-12</p><p><b>requester</b>: <a href="Practitioner-practitioner-owen-oncologist.html">Practitioner/practitioner-owen-oncologist</a> &quot; ONCOLOGIST&quot;</p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: oral twice a day every day</p><p><b>timing</b>: Starting 2020-04-01, Once</p><p><b>route</b>: Oral route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><p><b>maxDosePerAdministration</b>: 2</p></blockquote></div>
  </text>
  <status value="active"/>
  <intent value="order"/>
  <medication>
    <concept>
      <coding>
        <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
        <code value="2361290"/>
        <display value="tucatinib 150 MG Oral Tablet"/>
      </coding>
    </concept>
  </medication>
  <subject>🔗 
    <reference value="Patient/patient-example-kaitlyn-b"/>
  </subject>
  <authoredOn value="2020-03-12"/>
  <requester>🔗 
    <reference value="Practitioner/practitioner-owen-oncologist"/>
  </requester>
  <dosageInstruction>
    <text value="oral twice a day every day"/>
    <timing>
      <repeat>
        <boundsPeriod>
          <start value="2020-04-01"/>
        </boundsPeriod>
      </repeat>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="26643006"/>
        <display value="Oral route (qualifier value)"/>
      </coding>
    </route>
    <doseAndRate>
      <rateQuantity>
        <value value="150"/>
        <unit value="MG"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="MG"/>
      </rateQuantity>
    </doseAndRate>
    <maxDosePerAdministration>
      <value value="2"/>
    </maxDosePerAdministration>
  </dosageInstruction>
</MedicationRequest>